- Home
- MDIA vs ATRA Comparison
MDIA vs ATRA Comparison
Compare MDIA & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDIA
- ATRA
- Stock Information
- Founded
- MDIA 2019
- ATRA 2012
- Country
- MDIA United States
- ATRA United States
- Employees
- MDIA N/A
- ATRA N/A
- Industry
- MDIA Broadcasting
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MDIA Consumer Discretionary
- ATRA Health Care
- Exchange
- MDIA Nasdaq
- ATRA Nasdaq
- Market Cap
- MDIA 61.4M
- ATRA 65.1M
- IPO Year
- MDIA N/A
- ATRA 2014
- Fundamental
- Price
- MDIA $1.20
- ATRA $9.81
- Analyst Decision
- MDIA
- ATRA Hold
- Analyst Count
- MDIA 0
- ATRA 5
- Target Price
- MDIA N/A
- ATRA $26.88
- AVG Volume (30 Days)
- MDIA 103.6K
- ATRA 70.9K
- Earning Date
- MDIA 12-24-2024
- ATRA 11-12-2024
- Dividend Yield
- MDIA N/A
- ATRA N/A
- EPS Growth
- MDIA N/A
- ATRA N/A
- EPS
- MDIA N/A
- ATRA N/A
- Revenue
- MDIA $69,296,000.00
- ATRA $100,439,000.00
- Revenue This Year
- MDIA N/A
- ATRA $1,368.80
- Revenue Next Year
- MDIA N/A
- ATRA N/A
- P/E Ratio
- MDIA N/A
- ATRA N/A
- Revenue Growth
- MDIA 94.96
- ATRA 2111.34
- 52 Week Low
- MDIA $0.40
- ATRA $6.50
- 52 Week High
- MDIA $6.86
- ATRA $39.50
- Technical
- Relative Strength Index (RSI)
- MDIA 44.86
- ATRA 38.35
- Support Level
- MDIA $1.10
- ATRA $10.12
- Resistance Level
- MDIA $1.35
- ATRA $13.64
- Average True Range (ATR)
- MDIA 0.11
- ATRA 0.91
- MACD
- MDIA -0.00
- ATRA -0.39
- Stochastic Oscillator
- MDIA 26.53
- ATRA 3.28
About MDIA Mediaco Holding Inc.
MediaCo Holding Inc is a radio broadcasting media company operating in radio and digital advertising, premium programming and events. It has two radio stations, WQHT-FM and WBLS-FM, which serve the New York City metropolitan area. The company generates revenue from radio and outdoor advertising sales and events including sponsorships and ticket sales, licensing, and syndication.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).